Although our study included a relatively small number of patients, it suggests a potential role for sMR, Presepsin, and MCP-1 as biomarkers in differentiating between sepsis and SIRS in critically ill children, so more studies should be done on a larger number of children. This evidence concerns the gene LYPD4 and Sepsis.